Stay updated with breaking news from 64026810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 19,998 shares of the business’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $0.78, for a total value of $15,598.44. Following the completion of the transaction, the chief executive officer now owns 919,799 shares […]
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.27) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.03, RTT News reports. The firm had revenue of $20.50 million during the quarter, compared to analysts’ expectations of $20.94 million. Nektar […]
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “neutral” rating reissued by stock analysts at Mizuho in a report issued on Monday, Benzinga reports. They presently have a $6.00 target price on the biopharmaceutical company’s stock. Several other research analysts have also weighed in on the stock. Jefferies Financial Group raised shares of […]
Mizuho restated their neutral rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note issued to investors on Monday, Benzinga reports. Mizuho currently has a $6.00 target price on the biopharmaceutical company’s stock. A number of other research firms have also recently issued reports on NKTR. StockNews.com assumed coverage on shares […]
Mizuho reissued their neutral rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research report sent to investors on Monday morning, Benzinga reports. They currently have a $6.00 target price on the biopharmaceutical company’s stock. A number of other research firms also recently issued reports on NKTR. Jefferies Financial Group upgraded shares […]